Biosimilars Market Size Worth $61.47 Billion by 2025 | CAGR
34.2%: Grand View Research, Inc. - Seite 2
- Angina Pectoris Drugs Market - The global angina pectoris drugs market size was valued at USD 8.5 Billion in 2016 and is expected to grow at a CAGR of 3.2% during the forecast period.
- Kidney Cancer Drugs Market - The global kidney cancer drugs market size was valued at USD 4.4 billion in 2016 and is expected to exhibit a CAGR of 5.4% during the forecast period.
- Colorectal Cancer (CRC) Drugs/ Therapeutic Market - The global colorectal cancer drugs market size was valued at USD 8.6 billion in 2016, exhibiting a CAGR of 3.3% during the forecast period.
- Liver Cancer Drugs Market - The global liver cancer drugs market size was valued at USD 424 million in 2016. It is expected to progress at a CAGR of 19.4% during the forecast period.
Grand View Research has segmented the global biosimilars market on the basis of product, application, and region:
-
Biosimilars Product Outlook (Revenue, USD Million, 2014 - 2025)
-
Recombinant Non-glycosylated Proteins
- Human Growth Hormones
- Granulocyte Colony-stimulating Factor (G-CSF)
- Interferons
- Insulin
- Recombinant Glycosylated Proteins
- Erythropoietin
- Monoclonal Antibodies
- Follitropin
-
Recombinant Non-glycosylated Proteins
-
Biosimilars Application Outlook (Revenue, USD Million, 2014 - 2025)
- Oncology
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Others
-
Biosimilars Regional Outlook (Revenue, USD Million, 2014 - 2025)
-
North America
- U.S.
- Canada
-
Europe
- Germany
- U.K.
-
Asia Pacific
- China
- India
- RoW
-
North America
Lesen Sie auch
Explore the BI enabled intuitive market research database, Grand View Compass, by Grand View Research, Inc.